Drug Discovery World

MAY 28, 2024

A new eBook is now available for download entitled ‘Using imaging in drug discovery’. billion by 2030, growing at a CAGR of 15.3% from 2023 to 2030. The growth will in part by driven by an increase in the use of imaging modalities in drug research and development. Download ‘Using imaging in drug discovery’ now.

Drugs 130

Drugs Clinical Trials Marketing Disease 130

BioPharma Drive: Drug Pricing

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Drug Research 122

Drug Research Research Drugs 122

Drug Target Review

SEPTEMBER 21, 2023

The research showed that exposing O. The findings supported the possibility put forward by Cotton et al (2016) concerning the chance of repurposing these drugs for adulticidal treatment. Need for adulticidal drugs More than 99 percent of countries worldwide has been affected by this disease. volvulus.

Drugs 105

Drugs Treatment Disease Research 105

Vial

MAY 20, 2024

Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. The two broadest categories of drug development can be separated into the preclinical and clinical research stages. over this period.

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Discovery World

AUGUST 8, 2023

DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1.

Research 130

Research Pharmacy Pharmaceuticals Government 130

Drug Discovery World

NOVEMBER 22, 2023

The Francis Crick Institute has announced goals to reduce its operational carbon emissions by 50% by 2030, along with a longer-term target to be net zero carbon by 2040.

Science 147

Science Drugs Drug Research Research 147

The Pharma Data

APRIL 24, 2021

Novartis is advancing Research & Development of next-generation treatments to combat emerging drug resistance. R&D partnerships to combat drug-resistant malaria in Africa. The European & Developing Countries Clinical Trials Partnership (EDCTP) awarded a grant to the new PAMAfrica research consortium led by MMV.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52